U.S. expects to OK Pfizer shots for teens

As officials hope to reduce coronavirus cases and reopen schools in the fall, the Food and Drug Administration (FDA) is expected to authorize Pfizer’s vaccine for 12- to 15-year-olds by next week. Pfizer confirmed last month that its shot protects the younger age group from coronavirus.

What comes next? After the FDA’s approval, a federal vaccine advisory committee would meet to discuss whether to recommend the shots for teens. Shots would begin after the Centers for Disease Control and Prevention adopts the committee’s recommendation. A U.S. study on the use of Moderna’s vaccine in teens ages 12 to 17 is expected by the middle of the year. The FDA has allowed both Moderna and Pfizer to begin U.S. studies in children 11 and younger.

Dig deeper: Read Leah Hickman’s report in Vitals about the ethical implications of coronavirus vaccines.